ZS Pharma (ZSPH) Reports Publication of ZS-9 Phase 3 Data in NEJM
Tweet Send to a Friend
ZS Pharma (Nasdaq: ZSPH) announced the publication of previously unreleased detailed results from the ZS003 study in the New England ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE